These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 9426692)
1. Oncostatin M induces the differentiation of breast cancer cells. Douglas AM; Grant SL; Goss GA; Clouston DR; Sutherland RL; Begley CG Int J Cancer; 1998 Jan; 75(1):64-73. PubMed ID: 9426692 [TBL] [Abstract][Full Text] [Related]
2. Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M. Schrell UM; Koch HU; Marschalek R; Schrauzer T; Anders M; Adams E; Fahlbusch R J Neurosurg; 1998 Mar; 88(3):541-8. PubMed ID: 9488310 [TBL] [Abstract][Full Text] [Related]
3. Oncostatin M induces growth arrest of mammary epithelium via a CCAAT/enhancer-binding protein delta-dependent pathway. Hutt JA; DeWille JW Mol Cancer Ther; 2002 Jun; 1(8):601-10. PubMed ID: 12479220 [TBL] [Abstract][Full Text] [Related]
4. Oncostatin M-specific receptor mediates inhibition of breast cancer cell growth and down-regulation of the c-myc proto-oncogene. Liu J; Spence MJ; Wallace PM; Forcier K; Hellström I; Vestal RE Cell Growth Differ; 1997 Jun; 8(6):667-76. PubMed ID: 9186000 [TBL] [Abstract][Full Text] [Related]
5. An unexpected biochemical and functional interaction between gp130 and the EGF receptor family in breast cancer cells. Grant SL; Hammacher A; Douglas AM; Goss GA; Mansfield RK; Heath JK; Begley CG Oncogene; 2002 Jan; 21(3):460-74. PubMed ID: 11821958 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of growth and induction of differentiation of SMMC-7721 human hepatocellular carcinoma cells by Oncostatin M. Kong N; Zhang XM; Wang HT; Mu XP; Han HZ; Yan WQ Asian Pac J Cancer Prev; 2013; 14(2):747-52. PubMed ID: 23621231 [TBL] [Abstract][Full Text] [Related]
7. Oncostatin M-mediated growth inhibition of human glioblastoma cells does not depend on stat3 or on mitogen-activated protein kinase activation. Halfter H; Stögbauer F; Friedrich M; Serve S; Serve H; Ringelstein EB J Neurochem; 2000 Sep; 75(3):973-81. PubMed ID: 10936178 [TBL] [Abstract][Full Text] [Related]
8. Oncostatin M induces an acute phase response but does not modulate the growth or maturation-status of liver progenitor (oval) cells in culture. Matthews VB; Knight B; Tirnitz-Parker JE; Boon J; Olynyk JK; Yeoh GC Exp Cell Res; 2005 May; 306(1):252-63. PubMed ID: 15878349 [TBL] [Abstract][Full Text] [Related]
9. Oncostatin M and interleukin 6 inhibit cell cycle progression by prevention of p27kip1 degradation in HepG2 cells. Klausen P; Pedersen L; Jurlander J; Baumann H Oncogene; 2000 Jul; 19(32):3675-83. PubMed ID: 10951574 [TBL] [Abstract][Full Text] [Related]
10. Activation of Jak-Stat and MAPK2 pathways by oncostatin M leads to growth inhibition of human glioma cells. Halfter H; Friedrich M; Postert C; Ringelstein EB; Stögbauer F Mol Cell Biol Res Commun; 1999 May; 1(2):109-16. PubMed ID: 10356359 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of growth and induction of differentiation of glioma cell lines by oncostatin M (OSM). Halfter H; Lotfi R; Westermann R; Young P; Ringelstein EB; Stögbauer FT Growth Factors; 1998; 15(2):135-47. PubMed ID: 9505169 [TBL] [Abstract][Full Text] [Related]
12. CCAAT/Enhancer binding protein delta (c/EBPdelta) regulation and expression in human mammary epithelial cells: II. Analysis of activating signal transduction pathways, transcriptional, post-transcriptional, and post-translational control. Sivko GS; Sanford DC; Dearth LD; Tang D; DeWille JW J Cell Biochem; 2004 Nov; 93(4):844-56. PubMed ID: 15389878 [TBL] [Abstract][Full Text] [Related]
13. Oncostatin M-specific receptor expression and function in regulating cell proliferation of normal and malignant mammary epithelial cells. Liu J; Hadjokas N; Mosley B; Estrov Z; Spence MJ; Vestal RE Cytokine; 1998 Apr; 10(4):295-302. PubMed ID: 9617575 [TBL] [Abstract][Full Text] [Related]
14. Oncostatin M causes VEGF release from human airway smooth muscle: synergy with IL-1beta. Faffe DS; Flynt L; Mellema M; Whitehead TR; Bourgeois K; Panettieri RA; Silverman ES; Shore SA Am J Physiol Lung Cell Mol Physiol; 2005 Jun; 288(6):L1040-8. PubMed ID: 15665043 [TBL] [Abstract][Full Text] [Related]
15. Downregulation of osteoblast markers and induction of the glial fibrillary acidic protein by oncostatin M in osteosarcoma cells require PKCdelta and STAT3. Chipoy C; Berreur M; Couillaud S; Pradal G; Vallette F; Colombeix C; Rédini F; Heymann D; Blanchard F J Bone Miner Res; 2004 Nov; 19(11):1850-61. PubMed ID: 15476586 [TBL] [Abstract][Full Text] [Related]
16. Acquisition of agonistic properties of nonsteroidal antiandrogens after treatment with oncostatin M in prostate cancer cells. Godoy-Tundidor S; Hobisch A; Pfeil K; Bartsch G; Culig Z Clin Cancer Res; 2002 Jul; 8(7):2356-61. PubMed ID: 12114440 [TBL] [Abstract][Full Text] [Related]
17. Oncostatin M enhances the expression of prostaglandin E2 and cyclooxygenase-2 in astrocytes: synergy with interleukin-1beta, tumor necrosis factor-alpha, and bacterial lipopolysaccharide. Repovic P; Mi K; Benveniste EN Glia; 2003 Jun; 42(4):433-46. PubMed ID: 12730964 [TBL] [Abstract][Full Text] [Related]
18. Oncostatin M is a differentiation factor for myeloid leukemia cells. Bruce AG; Hoggatt IH; Rose TM J Immunol; 1992 Aug; 149(4):1271-5. PubMed ID: 1380037 [TBL] [Abstract][Full Text] [Related]
19. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines. Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102 [TBL] [Abstract][Full Text] [Related]